Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Did you mean isopropyl alcohol and amino associates virus?
Displaying drugs 14876 - 14900 of 14966 in total

2-((3'-TERTBUTYL-4'-HYDROXYPHENYL)AZO)BENZOIC ACID

Experimental

Nelotanserin

Nelotanserin has been used in trials studying the treatment of Lewy Body Dementia, Visual Hallucinations, Dementia With Lewy Bodies, and REM Sleep Behavior Disorder. It is a highly selective antagonist at the 5-HT2A serotonin receptor. It increases non-REM sleep, the most restorative phase of the sleep cycle, without sacrificing REM...
Investigational
Matched Description: … trials studying the treatment of Lewy Body Dementia, Visual Hallucinations, Dementia With Lewy Bodies, and …

Indole Naphthyridinone

Experimental

2-((3'-METHYL-4'-HYDROXYPHENYL)AZO)BENZOIC ACID

Experimental

4-(4-hydroxy-3-methylphenyl)-6-phenylpyrimidin-2(5H)-one

Experimental

2-((4'-HYDROXYPHENYL)-AZO)BENZOIC ACID

Experimental

2-(6-HYDROXY-1,3-BENZOTHIAZOL-2-YL)-1,3-THIAZOL-4(5H)-ONE

Experimental

(5R)-5-(4-{[(2R)-6-HYDROXY-2,5,7,8-TETRAMETHYL-3,4-DIHYDRO-2H-CHROMEN-2-YL]METHOXY}BENZYL)-1,3-THIAZOLIDINE-2,4-DIONE

Experimental

AMG-131

AMG-131 (T131), an orally-administered therapy, is expected to lower blood glucose in type II diabetic patients by improving the body’s ability to respond to insulin. T131 is a selective modulator of PPARg (peroxisome proliferator activated receptor gamma), a receptor involved in regulating the body’s ability to respond to insulin. T131...
Investigational
Matched Description: … is not structurally related to the thiazolidinedione class of PPARg agonists, which includes Actos and …

BMS-488043

BMS-488043 has been investigated as an anti-HIV agent.
Investigational

4-(2-HYDROXYPHENYLTHIO)-1-BUTENYLPHOSPHONIC ACID

Experimental

{4-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]phenoxy}acetic acid

Experimental

BMS-394136

BMS-394136 has been used in trials studying the diagnostic of Heart Diseases.
Investigational

Saroglitazar

Saroglitazar has been investigated for the treatment of Fatty Liver.
Investigational

CRx-139

CRx-139 is an oral synergistic combination drug candidates with novel mechanisms of action targeting multiple biological pathways simultaneously. It is a dissociated steroid designed to enhance the immuno-modulatory activity of a low-dose glucocorticoid steroid without a comparable increase in steroid-related side effects. The synergistic combination containing low doses of the...
Investigational
Matched Description: … The synergistic combination containing low doses of the glucocorticoid steroid prednisolone and the antidepressant …

(2S)-3-(1-{[2-(2-CHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL}-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID

Experimental

(2R)-N-HYDROXY-2-[(3S)-3-METHYL-3-{4-[(2-METHYLQUINOLIN-4-YL)METHOXY]PHENYL}-2-OXOPYRROLIDIN-1-YL]PROPANAMIDE

Experimental

4-[3-(3-NITROPHENYL)-1,2,4-OXADIAZOL-5-YL]BUTANOIC ACID

Experimental

2-((3',5'-DIMETHOXY-4'-HYDROXYPHENYL)AZO)BENZOIC ACID

Experimental

2-(4-HYDROXY-3-NITROPHENYL)ACETIC ACID

Experimental

Rivoglitazone

Rivoglitazone (INN) is a thiazolidinedione undergoing research for use in the treatment of type 2 diabetes. It is being developed by Daiichi Sankyo Co.
Experimental
Investigational

Tucaresol

Tucaresol has been used in trials studying the treatment of HIV Infections.
Investigational

(5-hydroxyindolo[1,2-a]quinazolin-7-yl)acetic acid

Experimental

N-{2,4-difluoro-3-[(5-pyridin-3-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]phenyl}ethanesulfonamide

Experimental

3-[3-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)quinoxalin-5-yl]phenol

Experimental
Displaying drugs 14876 - 14900 of 14966 in total